METABOLIC DiSORDERS

Rescue Therapy 

BASEDOW'S disease:     Treatment of hyperthyroidism
ADDISON'S disease:      Replacement of mineralcorticoid therapy during primary adrenocortical insufficiency of any etiology, or secondary adrenocortical insufficiency, combined with glucocorticoid.
SIADH:                           Treatment of the inappropriate secretion of antiduretic hormone syndrome. Paraneoplastic and iatrogenic origin. Neurological and non specific clinical signs.

ONCOLOGY

Acute Therapy

MULTIPLE MYELOMA:    Treatment Treatment of lymphoma, leukaemia, and carcinomae
MYCOSIS FUNGOIDES:  Replacement of mineralcorticoid therapy during primary adrenocortical insufficiency of any etiology, or secondary adrenocortical insufficiency, combined with glucocorticoid.
ELECTROLYTIC:              Treatment of the inappropriate secretion of antiduretic hormone syndrome.
DISORDERS                   Paraneoplastic and iatrogenic origin.
ANTI-EMETIC:                Prevention and treatment of protracted or acute, medium to severe episodes of nausea and vomiting caused by cytotoxic chemotherapy.

TRANSPLANT CARE

Supportive Therapy 

BONE-MARROW TRANS:  Alkylant for autograft and allograft transplantation.
PROPHILAXIS                    Used in prophylaxis of invasive fungal infections in patients with acute myelogenous leukemia and myelodysplastic

RYTHMO-EMERGENCY

CARE

Reset Heart-Failure 

ANTIARRHYTHMIC:          Emergency treatment of junctional tachycardia, also used as an aid for diagnosing wide or narrow complex tachycardia 
BETA-BLOCKER:                   Emergency treatment of sympathetic tachycardia and some forms of cardiac arrhythmia 
ANTIHYPERTENSIVE:      Some pre-eclampsia involving serious life-threatening breast 

RESPIRATORY                    Respiratory stimulant for intensive care.
DEPRESSION:                 Apnea in neonatalogy 

NEURO- PSYCHIATRY

Unique Therapy 

TRANSIENT INSOMNIA:   Used in Pediatric insomia treatment and for autistic disorders.
EPILEPSY:                           Partial or generalized (tonic-clonic) Epilepsies. Adults and children
IMAO:                                 Indicated for the treatment of anxiety disorders including those intrinsically linked with a depressive disorderY
ANTI-PSYCHOTIC:             Current treatment of pathologies on the schizophrenia spectrum and of chronic, non-schizophrenic delirium.

SUPPORTIVE CARE

Active Therapy 

XEROTOMIA:                        Symptomatic treatment of xerostomia (dry mouth) in patients with impaired salivary gland function and patent salivary ducts. Relief of chronic and temporary xerostomia, which may be a result of disease, medication, oncology therapy, (www.sst.care)
Wound & SKIN EMULSION:  Manage and relieve the burning, itching and pain experienced with various types of dermatoses, including radiation dermatitis, atopic dermatitis and allergic contact dermatitis. 

REVIVING THERAPIES.....

FOR PATIENT BENEFITS !

Hexim

Pharmaceuticals Inc.     

1-(201) 552-2341

© 2016 Proudly created by Hexim Pharmaceuticals Inc.

  • Twitter Social Icon
  • Facebook Social Icon

600 Meadowlands Parkway

Suite 149 - SECAUCUS -

07094 - New Jersey - USA.

Tel: 1 201 552 2341 -  Fax:1 201 552 2289

Web: https://www.Heximlab.com